“Efficacy and safety of regorafenib versus dinutuximab with chemotherapy in Chinese children with neuroblastoma”, Bangladesh J Pharmacol, vol. 14, no. 1, pp. 32–35, Feb. 2019, doi: 10.3329/bjp.v14i1.38807.